Centessa, formed earlier this year through a ten-way merger involving multiple spinouts, has completed a listing in the US.

Intel Capital looks set exit the marketing technology provider, which has filed to raise up to $100m on the New York Stock Exchange.

JD.com has followed up the December flotation of its JD Health spinoff by listing its Tencent and China Life-backed logistics vehicle.

Vision Fund is the largest shareholder of freight services provider Full Truck Alliance, which is reportedly seeking a $20bn valuation when it floats.

The Comcast, PayPal and Rakuten-backed micro-investing service is merging with Nasdaq-listed Pioneer Merger Corp at a $2.2bn post-transaction valuation.

The Gilbarco Veeder-Root, Varley Group and Cigna-backed electric vehicle charging technology developer will list through a $1.2bn reverse merger deal.

Access Industries and Takeda scored exits as the oncology therapy developer floated at the top of its range in an upsized offering.

The GlaxoSmithKline and Celgene-backed immunotherapy developer has revealed its intention to float on the Nasdaq Global Market.

The Pfizer, GlaxoSmithKline, Novartis, AbbVie and Astellas-backed oncology therapy developer is set to go public through a reverse takeover.

The payment software provide's shared popped on their first day after an IPO that followed two Goldman Sachs-backed funding rounds.